GILD is a stock I’ve traded off and on to unremarkable results. In the world of Biotech, it’s a low growth value stock and speaking personally, as long as it has a constructive chart it’s got a place in my portfolio, considering the market’s ongoing rotations and the need for balance. Note that a second position in GILD was added a few days ago.
GILD daily has ticked a higher high to go with the higher low shakeout on April 30. As yet it’s a potential (not actual) trend change, but it is constructive to change trend, given the higher high. RSI and MACD are fine, but could use a minor cool down. Resistance is just overhead at 69+.
GILD weekly shows that resistance but also very nice looking RSI and MACD, which are both positive but not overbought. That is the fuel to bust through resistance should GILD choose to do that.
The big picture monthly view shows the well tested support area at 55. It’s been tested 3 times since 2017 and the issue is that the more times support is tested, the weaker it tends to become. I’d call that a minor caveat at this point since the charts above indicate positive. But it would again become an issue if GILD starts weakening (key support at 67). Meanwhile, monthly RSI is positive and has ticked above its EMA 20 and MACD is still negative but in a constructive posture triggered up.
A reminder that chart based NFTRH+ updates are technical trade setup ideas, which may not be revisited as the technical parameters are already noted. These updates are meant as a starting point for your further research if interested. I will not personally buy every item highlighted and will sometimes sell (ref. Trade Log) any item that I do buy below target (assuming I’ve not stopped out or sold for some other reason) as I often do. Also please be aware that I am not a fundamental stock analyst. Due diligence is your responsibility.